IMMU-14. ONCOLYTIC ADENOVIRUS DELTA-24-RGD ENGINEERED TO EXPRESS 4-1BBL AS A THERAPEUTIC APPROACH FOR DIPG

Despite the advances in our understanding of pediatric diffuse midline gliomas (DMG) they remain the leading cause of pediatric death caused by cancer. Our group has demonstrated that the administration of Delta-24-RGD in DIPG models is safe and therapeutically efficacious. An on-going clinical tria...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Laspidea, Virginia, Puigdelloses, Montserrat, Martinez-Velez, Naiara, Garcia-Moure, Marc, Labiano, Sara, Ausejo, Iker, Patiño-García, Ana, Becher, Oren J, Jiang, Hong, Gupta, Sumit, Fueyo, Juan, Gomez-Manzano, Candelaria, M Alonso, Marta
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651280/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados